Surveillance, characterisation, and preservation of multidrug-resistant bacteria

The Lancet Infectious Diseases

Volumn 11, Issue 1, 2011, Pages 8-10

  Lesho, Emil ^a   Craft, David ^a   Kirkup, Benjamin C ^a   Waterman, Paige ^a   Summers, Amy ^a   Vahey, Maryanne T ^a   Kester, Kent E ^a   Bowden, Robert ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL INFECTION; INFECTION CONTROL; LETTER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

BIOLOGICAL SPECIMEN BANKS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MILITARY PERSONNEL; SENTINEL SURVEILLANCE; UNITED STATES; WOUND INFECTION;

EID: 78650234800     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70261-9     Document Type: Letter

References (15)

1. Jones A, Morgan D, Walsh A, et al. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect Dis 2006, 6:317-318.
2. Lewis T, Loman NJ, Bingle L, et al. High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J Hosp Infect 2010, 75:37-41.
3. Whitman TJ, Qasba SS, Timpone JG, et al. Occupational transmission of Acinetobacter baumannii from a United States serviceman wounded in Iraq to a health care worker. Clin Infect Dis 2008, 47:439-443.
4. Peleg AY, Hooper DC Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010, 362:1804-1813.
5. Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006, 42:657-668. for the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.
6. Slater F Cost-effective infection control success story: a case presentation. Emerg Infect Dis 2001, 7:293-294.
7. Lee BY, Bailey RR, Smith KJ, et al. Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis. Infect Control Hosp Epidemiol 2010, 31:598-606.
8. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumonia infection. Infect Control Hosp Epidemiol 2010, 31:620-626.
9. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985, 121:182-205.
10. Arias KM Surveillance programs in healthcare settings 2009, Association for Professionals in Infection Control and Epidemiology, Inc (APIC), Washington, DC, USA. 2nd edn.
11. McQuillen DP, Petrak RM, Wasserman RB, Nahass RG, Scull JA, Martinelli LP The value of infectious diseases specialists: non-patient care activities. Clin Infect Dis 2008, 47:1051-1063.
12. Kaye KS, Engemann JJ, Fulmer EM, Clark CC, Noga EM, Sexton DJ Favorable impact of an infection control network on nosocomial infection rates in community hospitals. Infect Control Hosp Epidemiol 2006, 27:228-232.
13. Apisarnthanarak A, Fraser VJ Feasibility and efficacy of infection-control interventions to reduce the number of nosocomial infections and drug-resistant microorganisms in developing countries: what else do we need?. Clin Infect Dis 2009, 48:22-24.
14. Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009, 136:127-148. for the Cooperative Antimicrobial Therapy of Septic Shock Database Research Group.
15. Lynn J, Baily MA, Bottrell M, et al. The ethics of using quality improvement methods in health care. Ann Intern Med 2007, 146:666-673.